Janssen hands back rights to imetelstat

27th September 2018 Uncategorised 0

Janssen Biotech has decided to terminate a collaboration and license agreement with Geron Corp for experimental cancer drug imetelstat.

More: Janssen hands back rights to imetelstat
Source: News